Suzuki Hidenori, Muramatsu Masatoshi, Tanaka Katsuhiro, Fujiwara Hiroaki, Kojima Tadashi, Taki Waro
Department of Neurosurgery, Mie University, Graduate School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan.
J Neurol. 2006 Sep;253(9):1170-6. doi: 10.1007/s00415-006-0184-1. Epub 2006 Apr 28.
Subarachnoid hemorrhage (SAH) is a common cause of chronic hydrocephalus. Blood in the subarachnoid space is intracranially metabolized to bilirubin and iron, and free iron is thereafter detoxified by ferritin. However, no studies have reported the relationship between intracranial heme metabolism and chronic hydrocephalus after SAH. The goal of this prospective study was to clarify the relationship between intracranial heme metabolism and chronic hydrocephalus after SAH.
The authors measured the levels of bilirubin, iron and ferritin in the cerebrospinal fluid (CSF) of 70 consecutive patients with aneurysmal SAH of Fisher computed tomography Group III, and determined the relationship between these substances' levels and hydrocephalus requiring ventriculoperitoneal shunting.
The CSF concentrations of ferritin and inflammatory cells were significantly higher in shunted patients (n = 27) than in non-shunted patients (n = 43) on Days 3 and 4 (p < 0.05 in ferritin and p < 0.01 in inflammatory cells) and 11 to 14 (p < 0.005 in ferritin) post-SAH. These results were independent of other clinical factors. The occurrence of chronic hydrocephalus was not affected by the extent of the intracranial heme metabolism in terms of the bilirubin and iron levels.
This is the first study to show that patients who subsequently had chronic hydrocephalus requiring CSF shunting were associated with higher CSF levels of ferritin in the acute stage of SAH. Higher CSF ferritin levels may not reflect the amount of blood in the subarachnoid space that was intracranially metabolized, but rather more intense subarachnoid inflammatory reactions which may cause chronic hydrocephalus after SAH.
蛛网膜下腔出血(SAH)是慢性脑积水的常见病因。蛛网膜下腔内的血液在颅内代谢为胆红素和铁,游离铁随后被铁蛋白解毒。然而,尚无研究报道SAH后颅内血红素代谢与慢性脑积水之间的关系。这项前瞻性研究的目的是阐明SAH后颅内血红素代谢与慢性脑积水之间的关系。
作者测量了70例连续的Fisher计算机断层扫描III级动脉瘤性SAH患者脑脊液(CSF)中的胆红素、铁和铁蛋白水平,并确定了这些物质水平与需要脑室腹腔分流术的脑积水之间的关系。
SAH后第3天和第4天以及第11至14天,分流患者(n = 27)的脑脊液铁蛋白和炎症细胞浓度显著高于未分流患者(n = 43)(铁蛋白p < 0.05,炎症细胞p < 0.01)以及(铁蛋白p < 0.005)。这些结果与其他临床因素无关。就胆红素和铁水平而言,慢性脑积水的发生不受颅内血红素代谢程度的影响。
这是第一项表明随后发生需要脑脊液分流的慢性脑积水的患者在SAH急性期脑脊液铁蛋白水平较高的研究。脑脊液铁蛋白水平升高可能并不反映颅内代谢的蛛网膜下腔出血量,而是可能导致SAH后慢性脑积水的更强烈的蛛网膜下腔炎症反应。